ModelEdge

CNS Pharmaceuticals Inc.
CNSP
Filing Type8-K
Filing Date3/1/2026
Updated3/3/26, 2:03 AM

Filing

8-K
Earnings Release

Exhibits

8-KChanges in Board, Management or Compensation
EX-10.1EMPLOYMENT AGREEMENT BETWEEN LYNNE KELLEY AND CNS PHARMACEUTICALS, INC.
EX-10.2SEPARATION AND SEVERANCE AGREEMENT BETWEEN SANDRA SILBERMAN AND CNS PHARMACEUTICALS, INC.